Scott A. Holmes, Chief Financial Officer at KERYX BIOPHARMACEUTICALS INC (KERX), sold 1,445 shares at $7.14 ($10K) on 2017-07-31, disclosed to the SEC on 2017-08-01.
Open-market sale of $10k KERX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| KERX | SELL | 2018-08-16 | $4K | — | Filing → |
| KERX | SELL | 2018-07-31 | $9K | — | Filing → |
| KERX | SELL | 2018-05-16 | $7K | — | Filing → |